BioKorf Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 3

BioKorf General Information


Developer of prefabricated drug dosages intended for next-generation biopharmaceuticals. The company's services offer a flexible and integrated arrangement of prefabricated working parts assembled as a drug delivery system that provides patient-centered medicine and ensures better recovery, enabling healthcare professionals to provide multiple dosage form types into one unique form.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 1008 Ravinia Road
  • West Lafayette, IN 47906
  • United States
+1 (765) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioKorf Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 31-Jul-2015 $50K 0000 Completed Startup
2. Early Stage VC 19-May-2015 0000 0000 Completed Startup
1. Accelerator/Incubator 07-Oct-2014 Completed Startup
To view BioKorf’s complete valuation and funding history, request access »

BioKorf Executive Team (2)

Name Title Board Seat Contact Info
Andrew Otte Ph.D Chief Executive Officer & Co-Founder
Teresa Carvajal Chief Operating Officer
To view BioKorf’s complete executive team members history, request access »

BioKorf Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
Purdue Research Foundation Limited Partner Minority 000 0000 000000 0
To view BioKorf’s complete investors history, request access »